Cite
MLA Citation
Frédéric Peyrade et al.. “Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.” Lancet, vol. 4, no. 1, 2017, pp. e46–e55. http://access.bl.uk/ark:/81055/vdc_100039989062.0x000013